Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Calla Lily Clinical Care Ltd

Clinical trials sponsored by Calla Lily Clinical Care Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New vaginal progesterone device tested for safety and ease of use Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New vaginal progesterone device tested for safety and ease of use

Symptom relief Recruiting now

This early-stage trial tests a new vaginal product (Callavid) that delivers 400mg of progesterone to women with luteal phase insufficiency, a condition that can affect fertility. The study compares it to an existing pessary to see if it is safe, well-tolerated, and easy to use. 2…

Phase 1 • Sponsor: Calla Lily Clinical Care Ltd • Aim: Symptom relief

Last updated Sep 12, 2026 00:00 UTC